Physician profile
Mark A Gardner
NPI 1396279949
$3,334.21
in general payments reported to CMS, 2019-2025
10 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $90.88 · 2023: $393 · 2024: $2,283 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803 · Travel and Lodging: $1,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,802.85 |
| Travel and Lodging | $1,270.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,319.83 | 2022-2025 | |
| Stryker Corporation | $332.94 | 2023-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Smartlock |
| Straumann USA LLC | $225.70 | 2021-2024 | |
| Depuy Synthes Sales INC. | $170.20 | 2023 | Trumatch |
| Biohorizons Implant Systems INC. | $108.47 | 2021 | |
| Nobel Biocare USA | $86.77 | 2021-2023 | Nobelactive |
| Keystone Dental INC. | $45.16 | 2022 | |
| Zimmer Biomet Holdings, INC. | $27.78 | 2021 | |
| Henry Schein, INC. | $14.63 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Ace Surgical Supply Co., INC. | $2.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.